MV130

· Inmunotek S.L.

Drug timelines are a Plus or Pro feature.

2 regulatory and trial events tracked for MV130, covering 2024-09-19 to 2025-10-02. Get the full timeline:

Most recent: Clinical Trial Update: Evaluation of the Efficacy and Safety of MV130 in Chronic Obstructive Pulmonary Disease (COPD) [Phase 2, Phase 3]